Table 1. Patient characteristics and therapeutic disposition.
| Variables | Frequency |
|---|---|
| Age, average [range], years | 70 [48–84] |
| Male, n (%) | 39 (81.3) |
| Asbestos exposure, n (%) | 28 (58.3) |
| Histology, n (%) | |
| Epithelioid | 34 (70.8) |
| Sarcomatoid | 4 (8.3) |
| Biphasic | 7 (14.6) |
| Other | 3 (6.3) |
| Clinical stage, n (%) | |
| I | 9 (18.8) |
| II | 5 (10.4) |
| III | 23 (47.9) |
| IV | 11 (22.9) |
| Management, n (%) | |
| EPP (SMART approach) | 17 (35.4) |
| Chemoradiation | 2 (4.2) |
| Chemotherapy | 10 (20.8) |
| Palliative care | 12 (25.0) |
| No information | 7 (14.6) |
| LN size, mean ± SD (mm) | 6.8±3.8 |
| Number LN sampled/patient, average [range] | 3.4 [1–5] |
| Number passes/LN, mean ± SD [range] | 2.6±1.1 [1–9] |
| Prevalence of mediastinal nodal metastasis | 17/48 (35.4) |
EPP, extrapleural pneumonectomy; LN, lymph node; SD, standard deviation; SMART, Surgery for Mesothelioma After Radiation Therapy.